The aforementioned research indicated that as an important RNA m7G modification regulator, WBSCR22 plays a significant role in the growth and invasion of HCC cells and can be considered a potential therapeutic target for HCC in-depth research. The gene discussed is BUD23; the disease is hepatocellular carcinoma.